Two Moroccan investors are preparing to take control of a key player in the pharmaceutical industry. The deal involves a joint acquisition of Corporate Investment Holding SA by Tettucio Pharma Holdings SAS and Compagnie Financière Holding Atlas SA—two firms headquartered in Casablanca with growing influence in finance and healthcare.
Tettucio Pharma Holdings SAS is an investment company focused on acquiring equity stakes across a range of sectors. Compagnie Financière Holding Atlas SA, meanwhile, operates more broadly in financial services, offering expertise in investment banking, asset management, brokerage, and real estate. Together, these two entities are positioning themselves to gain a strategic foothold in the health sector through this joint takeover.
Corporate Investment Holding SA, the target of the acquisition, oversees a diverse group of businesses that span the pharmaceutical value chain. Among its subsidiaries is Polymédic, a manufacturer and marketer of pharmaceutical products, and Pharmena, which focuses on distributing dietary supplements. The group’s assets also include Foncière Amyot, which manages the company’s real estate holdings, and Promaceutique, a service provider specializing in the promotion and communication of health and cosmetic products.
The deal reflects a growing convergence between pharmaceutical production and the booming market for nutritional supplements. With this acquisition, the investors are not just entering a lucrative sector—they’re gaining control of an integrated network that spans manufacturing, distribution, marketing, and real estate. It’s a strategic consolidation that could reshape the landscape of Morocco’s health and wellness industry.
